Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Blood

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Blood|May 30, 2015
ATRA and ATO team up against NPM1Steven Grant
Blood|January 11, 2003
Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cellsShujie Wang, Zhiliang Wang, Paul Dent, et al.
Blood|September 17, 2005
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanismGirija Dasmahapatra, Mohamed Rahmani, Paul Dent, et al.
Blood|September 6, 2005
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stressNing Gao, Mohamed Rahmani, Xianglin Shi, et al.
Blood|January 16, 2007
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825Tri K Nguyen, Mohamed Rahmani, Hisashi Harada, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Blood|October 18, 2002
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanismYun Dai, Terry H Landowski, Steven T Rosen, et al.
Blood|August 2, 2003
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571Chunrong Yu, Mohamed Rahmani, Daniel Conrad, et al.
Blood|February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationYun Dai, Payal Khanna, Shuang Chen, et al.
Blood|December 3, 2003
Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cellsYun Dai, Xin-Yan Pei, Mohamed Rahmani, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Blood|May 30, 2015
ATRA and ATO team up against NPM1Steven Grant
Blood|January 11, 2003
Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cellsShujie Wang, Zhiliang Wang, Paul Dent, et al.
Blood|September 17, 2005
The tyrphostin adaphostin interacts synergistically with proteasome inhibitors to induce apoptosis in human leukemia cells through a reactive oxygen species (ROS)-dependent mechanismGirija Dasmahapatra, Mohamed Rahmani, Paul Dent, et al.
Blood|September 6, 2005
Synergistic antileukemic interactions between 2-medroxyestradiol (2-ME) and histone deacetylase inhibitors involve Akt down-regulation and oxidative stressNing Gao, Mohamed Rahmani, Xianglin Shi, et al.
Blood|January 16, 2007
MEK1/2 inhibitors sensitize Bcr/Abl+ human leukemia cells to the dual Abl/Src inhibitor BMS-354/825Tri K Nguyen, Mohamed Rahmani, Hisashi Harada, et al.
Blood|March 25, 2004
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanismsYun Dai, Mohamed Rahmani, Xin-Yan Pei, et al.
Blood|October 18, 2002
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanismYun Dai, Terry H Landowski, Steven T Rosen, et al.
Blood|August 2, 2003
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571Chunrong Yu, Mohamed Rahmani, Daniel Conrad, et al.
Blood|February 1, 2007
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationYun Dai, Payal Khanna, Shuang Chen, et al.
Blood|December 3, 2003
Interruption of the NF-kappaB pathway by Bay 11-7082 promotes UCN-01-mediated mitochondrial dysfunction and apoptosis in human multiple myeloma cellsYun Dai, Xin-Yan Pei, Mohamed Rahmani, et al.
Pageof 3